NCT00221338View on ClinicalTrials.gov

Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions
Postoperative DeliriumPostoperative PainOpioid UseHospital Length of Stay
Interventions
DRUG

Gabapentin

This is a Double blind, placebo-controlled experimental study in which gabapentin adjusted for renal clearance (or placebo) is given preoperatively and also the first three postoperative days

Trial Locations (1)

94143-0648

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00221338 - Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain | Biotech Hunter | Biotech Hunter